Applications

From imaging to therapy

NuclearMediX translates platform chemistry into practical applications across imaging, theranostics, and distributed manufacturing.

PET Diagnostics

  • Sensitive detection and staging of neuroendocrine tumours (NETs) using SSTR-targeted imaging.
  • Support for treatment planning and monitoring, including peptide receptor radionuclide therapy (PRRT) decision-making.
  • Potential expansion to additional SSTR-positive oncology indications as evidence matures.

Theranostics

  • Pair diagnostic imaging ligands with therapeutic radionuclides using the same targeting framework.
  • Enable patient stratification and therapy alignment through consistent biology.
  • Support multiple therapeutic radionuclide options as programme needs evolve.

Distributed Manufacturing

  • Cassette-enabled synthesis supporting standardised, multi-site production.
  • Designed for technology transfer to hospital and contract radiopharmacies.
  • Quality by design (QbD) aligned with operational and regulatory requirements.
Stakeholder Use Cases

Supporting care teams and nuclear medicine departments

Clinician speaking with a patient
Oncologists

Enhancing cancer care for patients

Scalable SSTR-targeted PET access can support diagnosis, treatment planning, patient management, and monitoring.

PET/CT scanner in a clinical imaging room
Nuclear Medicine Departments

Future-proofing SSTR-targeted PET diagnosis

Standardised cassette workflows are intended to support reliable supply and multi-site implementation.

Ready to collaborate?

We work with stakeholders across hospitals, radiopharmacies, and pharma/biotech partners.

View Partnering Options